Introduction to COX inhibitors

被引：13
作者：
Biava, Mariangela [1 ]
机构：
[1] Sapienza Univ, Dipartimento Chim & Tecnol Farmaco, Ple A Moro 5, I-00185 Rome, Italy
来源：
FUTURE MEDICINAL CHEMISTRY | 2018年 / 10卷 / 15期
关键词：
SELECTIVE-INHIBITION; CYCLOOXYGENASE; 2; INFLAMMATION; DERIVATIVES; PREVENTION; NSAIDS; RISK;
D O I：
10.4155/fmc-2018-0159
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：1737 / 1740
页数：4
相关论文
共 18 条
  • [1] Designing Multitarget Anti-inflammatory Agents: Chemical Modulation of the Lumiracoxib Structure toward Dual Thromboxane Antagonists-COX-2 Inhibitors
    Bertinaria, Massimo
    Shaikh, Mohammed Abrar Abdul Gaffar
    Buccellati, Carola
    Cena, Clara
    Rolando, Barbara
    Lazzarato, Loretta
    Fruttero, Roberta
    Gasco, Alberto
    Hoxha, Malvina
    Capra, Valerie
    Sala, Angelo
    Rovati, G. Enrico
    [J]. CHEMMEDCHEM, 2012, 7 (09) : 1647 - 1660
  • [2] Enlarging the NSAIDs Family: Ether, Ester and Acid Derivatives of the 1,5-Diarylpyrrole Scaffold as Novel Anti-Inflammatory and Analgesic Agents
    Biava, M.
    Porretta, G. C.
    Poce, G.
    Battilocchio, C.
    Botta, M.
    Manetti, F.
    Rovini, M.
    Cappelli, A.
    Sautebin, L.
    Rossi, A.
    Pergola, C.
    Ghelardini, C.
    Galeotti, N.
    Makovec, F.
    Giordani, A.
    Anzellotti, P.
    Tacconelli, S.
    Patrignani, P.
    Anzini, M.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2011, 18 (10) : 1540 - 1554
  • [3] Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors
    Biava, Mariangela
    Battilocchio, Claudio
    Poce, Giovanna
    Alfonso, Salvatore
    Consalvi, Sara
    Di Capua, Angela
    Calderone, Vincenzo
    Martelli, Alma
    Testai, Lara
    Sautebin, Lidia
    Rossi, Antonietta
    Ghelardini, Carla
    Mannelli, Lorenzo Di Cesare
    Giordani, Antonio
    Persiani, Stefano
    Colovic, Milena
    Dovizio, Melania
    Patrignani, Paola
    Anzini, Maurizio
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (02) : 772 - 786
  • [4] Structure-activity relationships for the synthesis of selective cyclooxygenase 2 inhibitors: an overview (2009-2016)
    Carullo, G.
    Galligano, F.
    Aiello, F.
    [J]. MEDCHEMCOMM, 2017, 8 (03) : 492 - 500
  • [5] COX inhibitors Indomethacin and Sulindac derivatives as antiproliferative agents: Synthesis, biological evaluation, and mechanism investigation
    Chennamaneni, Snigdha
    Zhong, Bo
    Lama, Rati
    Su, Bin
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 56 : 17 - 29
  • [6] Structural basis for selective inhibition of Cyclooxygenase-1 (COX-1) by diarylisoxazoles mofezolac and 3-(5-chlorofuran-2-yl)-5-methy1-4-phenylisoxazole (P6)
    Cingolani, Gino
    Panella, Andrea
    Perrone, Maria Grazia
    Vitale, Paola
    Di Mauro, Giuseppe
    Fortuna, Cosimo G.
    Armen, Roger S.
    Ferorelli, Savina
    Smith, William L.
    Scilimati, Antonio
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 138 : 661 - 668
  • [7] COX inhibitors: a patent review (2011-2014)
    Consalvi, Sara
    Biava, Mariangela
    Poce, Giovanna
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2015, 25 (12) : 1357 - 1371
  • [8] Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer
    Dannenberg, AJ
    Altorki, NK
    Boyle, JO
    Dang, C
    Howe, LR
    Weksler, BB
    Subbararnaiah, K
    [J]. LANCET ONCOLOGY, 2001, 2 (09) : 544 - 551
  • [9] Role of Dose Potency in the Prediction of Risk of Myocardial Infarction Associated With Nonsteroidal Anti-Inflammatory Drugs in the General Population
    Garcia Rodriguez, Luis Alberto
    Tacconelli, Stefania
    Patrignani, Paola
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (20) : 1628 - 1636
  • [10] Role of PPARγ in COX-2 Activation in Mycobacterial Pulmonary Inflammation
    Kogiso, Mari
    Shinohara, Tsutomu
    Dorey, C. Kathleen
    Shibata, Yoshimi
    [J]. INFLAMMATION, 2012, 35 (05) : 1685 - 1695
12